Production of an allergic inflammation model using human lungs resected by a surgical operation and its application to drug discovery for the treatment of asthma

利用外科手术切除的人肺制作过敏性炎症模型及其在治疗哮喘的药物发现中的应用

基本信息

  • 批准号:
    17590478
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

In order to resolve a problem concerning species differences in pharmacological science, we tried to make an inflammation model using human lung tissues obtained from patients with lung cancer after surgical resection. When the chopped lung fragments passively sensitized with human IgE were incubated with anti-human IgE antibody, a significant amount of cysteinyl-leukotrienes (cysLTs) was generated in comparison with the control (without anti-IgE). The addition of human C3a or C5a alone did not generate cysLTs. The co-addition, however, of C5a at doses of 1.0 ng/ml to the anti-IgE antibody further potentiated cysLT production. Consequently, an allergic inflammation model in which complement activation was involved as a pathophysiological mechanism was produced. Either a novel C5a receptor complementary peptide or a C5a receptor antagonist inhibited cysLT production in a dose-dependent manner by the human lung fragments following the anaphylactic reaction in the presence of 1 ng/ml C5a. … More Since there are consideable species differences in primary structure of anaphylatoxins and those receptors, this model using human lung tissues may be valuable to perform screening for a novel drug. In contrast, the shortage of suitable human tissues and lack of methods for stable preservation are hindering to produce an adequate model using human tissues. After lung tissues were obtained from patients with lung cancer, they were kept at -5℃ or 4℃ for as many as 5 days, and then they were histologically and biochemically examined. Although the tissues preserved at-5℃ had an almost normal morphology with intact cilia on bronchial epithelium and normal endothelium, the tissues stored at 4℃ showed degradation of these structures. Single-stranded DNA, a sign of DNA cleavage, was frequently noted in tissues stored at 4℃, but only rarely observed at -5℃. A significant amount of cysLTs was generated by anaphylactic reaction from tissues stored at 5℃ for 3 days, but there was no response to antibody stimulation from tissues at 4℃. Therefore, such the novel preservation of human tissues as super-cooling system may facilitate availability of human tissues in medical science. Less
为了解决药理学中的物种差异问题,我们尝试使用从手术切除后的肺癌患者获得的人肺组织制作炎症模型。当用人IgE被动致敏的切碎的肺碎片与抗人IgE抗体孵育时,与对照(无抗IgE)相比,产生了显著量的半胱氨酰-白三烯(cysLT)。单独添加人C3 a或C5 a不产生cysLT。然而,以1.0 ng/ml的剂量向抗IgE抗体中共添加C5 a进一步增强了cysLT的产生。因此,产生了其中补体激活作为病理生理机制参与的过敏性炎症模型。无论是一种新的C5 a受体互补肽或C5 a受体拮抗剂抑制cysLT生产的剂量依赖性方式由人肺碎片过敏反应后,在1 ng/ml C5 a的存在下。 ...更多信息 由于过敏毒素及其受体的一级结构存在明显的种属差异,因此使用人肺组织的模型可能对筛选新药有价值。相反,缺乏合适的人体组织和缺乏稳定保存的方法阻碍了使用人体组织产生适当的模型。取肺癌患者的肺组织,在-5℃或4℃下保存5天,然后进行组织学和生化检查。尽管在-5 ℃保存的组织具有几乎正常的形态,支气管上皮上的纤毛完整,内皮正常,但在4℃保存的组织显示这些结构的降解。在4℃下储存的组织中经常观察到单链DNA,这是DNA裂解的标志,但在-5℃下很少观察到。在5℃下储存3天的组织中,过敏反应产生了大量的cysLT,但在4℃下,组织对抗体刺激无反应。因此,这种新型的人体组织保存系统,如过冷系统,可以促进人体组织在医学科学中的可用性。少

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
補体系と炎症
补体系统与炎症
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shirai N;Sugimoto M;Kodaira C;Nishino M;Ikuma M;Kajimura M;Ohashi K;Ishizaki T;Hishida A;Furuta T;阿部 正義
  • 通讯作者:
    阿部 正義
Contribution of anaphylatoxins to allergic inflammation in human lungs
过敏毒素对人类肺部过敏性炎症的影响
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M.Abe;et al.
  • 通讯作者:
    et al.
Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule
  • DOI:
    10.1016/j.freeradbiomed.2005.10.057
  • 发表时间:
    2006-03-15
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Abe, M;Hayashi, Y;Tanaka, K
  • 通讯作者:
    Tanaka, K
呼吸器疾患と補体系
呼吸系统疾病和补体系统
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kanai H;Marushima H;Kimura F;Iwaki T;Ohkawa K;Yanaga K;Matsuura T.;et al.;横尾 宏毅 他;阿部 正義
  • 通讯作者:
    阿部 正義
[Complement activation and inflammation].
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ABE Masayoshi其他文献

ABE Masayoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ABE Masayoshi', 18)}}的其他基金

Analysis for roles of complement and arachidonate metabolites in occurrence and progression of ARDS.
补体和花生四烯酸代谢物在ARDS发生和进展中的作用分析。
  • 批准号:
    03670403
  • 财政年份:
    1991
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
  • 批准号:
    30873315
  • 批准年份:
    2008
  • 资助金额:
    31.0 万元
  • 项目类别:
    面上项目
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
  • 批准号:
    30740048
  • 批准年份:
    2007
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
  • 批准号:
    30672268
  • 批准年份:
    2006
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Studentship
Creating healthier homes for children with asthma:Developing a predictive model for environmental
为哮喘儿童创建更健康的家庭:开发环境预测模型
  • 批准号:
    2908612
  • 财政年份:
    2024
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Innate immune regulation of lung inflammation through mitochondrial dynamics
通过线粒体动力学调节肺部炎症的先天免疫
  • 批准号:
    10659953
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
NHERF1 regulates MRGPRX2/MrgprB2 responses in mast cells
NHERF1 调节肥大细胞中的 MRGPRX2/MrgprB2 反应
  • 批准号:
    10711042
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了